Yanfei Xin

1.1k total citations
39 papers, 875 citations indexed

About

Yanfei Xin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Yanfei Xin has authored 39 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Physiology. Recurrent topics in Yanfei Xin's work include Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Ginseng Biological Effects and Applications (7 papers) and Amino Acid Enzymes and Metabolism (6 papers). Yanfei Xin is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Ginseng Biological Effects and Applications (7 papers) and Amino Acid Enzymes and Metabolism (6 papers). Yanfei Xin collaborates with scholars based in China, United States and Switzerland. Yanfei Xin's co-authors include Xuan Yao-xian, Zhenqiang You, Guoliang Zhou, Lili Wan, Cheng Guo, Jinliang Peng, Liqiang Gu, Yunxiang Chen, Haiyan Gao and Sheng Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Yanfei Xin

38 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanfei Xin China 19 404 178 106 99 94 39 875
Farhan Rizvi United States 19 366 0.9× 165 0.9× 67 0.6× 109 1.1× 68 0.7× 34 884
Joe Eun Son South Korea 21 447 1.1× 118 0.7× 72 0.7× 82 0.8× 100 1.1× 35 1.2k
Osama M. Ashour Saudi Arabia 14 250 0.6× 180 1.0× 147 1.4× 99 1.0× 36 0.4× 34 820
Yun-Hee Lee South Korea 16 391 1.0× 110 0.6× 113 1.1× 70 0.7× 120 1.3× 21 1.1k
Pavol Janega Slovakia 19 271 0.7× 94 0.5× 151 1.4× 42 0.4× 79 0.8× 88 932
Gwi Ran Kim South Korea 18 473 1.2× 142 0.8× 121 1.1× 39 0.4× 64 0.7× 22 818
Eman M. Mantawy Egypt 17 234 0.6× 209 1.2× 144 1.4× 63 0.6× 57 0.6× 27 817
Yilin Sun China 15 338 0.8× 109 0.6× 51 0.5× 91 0.9× 48 0.5× 48 767
Sin Young Choi South Korea 18 471 1.2× 136 0.8× 122 1.2× 37 0.4× 68 0.7× 26 823
Jingwei Tian China 22 497 1.2× 77 0.4× 213 2.0× 56 0.6× 125 1.3× 52 1.1k

Countries citing papers authored by Yanfei Xin

Since Specialization
Citations

This map shows the geographic impact of Yanfei Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfei Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfei Xin more than expected).

Fields of papers citing papers by Yanfei Xin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfei Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfei Xin. The network helps show where Yanfei Xin may publish in the future.

Co-authorship network of co-authors of Yanfei Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfei Xin. A scholar is included among the top collaborators of Yanfei Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfei Xin. Yanfei Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiao, Liang, Xiaojing Han, Lulu Xiao, et al.. (2024). Npc1 deficiency impairs microglia function via TREM2-mTOR signaling in Niemann-Pick disease type C. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167478–167478. 2 indexed citations
2.
Chen, Maohui, Ren‐Wang Peng, Yanfei Xin, et al.. (2024). Advancing cancer therapy: new frontiers in targeting DNA damage response. Frontiers in Pharmacology. 15. 1474337–1474337. 12 indexed citations
3.
Rahman, Mosiur, Quanle Xu, Rong Liu, et al.. (2024). Genome-Wide Analysis for Yield-Related Agronomic and Biochemical Traits of Chinese and Bangladeshi Grass Pea Genotypes Using SSR Markers. Phyton. 93(8). 1781–1804. 1 indexed citations
4.
Wu, Youping, et al.. (2021). Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity. Phytomedicine. 88. 153597–153597. 20 indexed citations
5.
Zhang, Sheng, Lin Lin, Dongying Liu, et al.. (2020). Modulatory effect of metformin on cardiotoxicity induced by doxorubicin via the MAPK and AMPK pathways. Life Sciences. 249. 117498–117498. 35 indexed citations
6.
Zhang, Sheng, Lin Yang, Lili Li, et al.. (2019). Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators. BMC Complementary and Alternative Medicine. 19(1). 317–317. 35 indexed citations
7.
Li, Lili, Sheng Zhang, Yanfei Xin, et al.. (2018). Role of Quzhou Fructus Aurantii Extract in Preventing and Treating Acute Lung Injury and Inflammation. Scientific Reports. 8(1). 1698–1698. 31 indexed citations
8.
Gu, Liqiang, Yanfei Xin, Sheng Zhang, et al.. (2016). Potential accumulation of protopanaxadiol-type ginsenosides in six-months toxicokinetic study of SHENMAI injection in dogs. Regulatory Toxicology and Pharmacology. 83. 5–12. 10 indexed citations
9.
Zhang, Xiangrong, Yanfei Xin, Xuan Yao-xian, et al.. (2016). Oral subchronic toxicity evaluation of a novel antitumor agent 25-methoxydammarane-3, 12, 20-triol from Panax notoginseng in Sprague–Dawley rats. Regulatory Toxicology and Pharmacology. 77. 240–251. 6 indexed citations
10.
Ye, Huadan, Qingxiao Hong, Xiaoying Chen, et al.. (2015). Association of seven thrombotic pathway gene CpG-SNPs with coronary heart disease. Biomedicine & Pharmacotherapy. 72. 98–102. 9 indexed citations
12.
Ye, Huadan, Linlin Tang, Xuting Xu, et al.. (2015). Positive Association between APOA5 rs662799 Polymorphism and Coronary Heart Disease: A Case-Control Study and Meta-Analysis. PLoS ONE. 10(8). e0135683–e0135683. 21 indexed citations
13.
Huang, Tao, Xiaoying Chen, Qingxiao Hong, et al.. (2015). Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients. Scientific Reports. 5(1). 8897–8897. 64 indexed citations
14.
Xin, Yanfei, Lili Wan, Jinliang Peng, & Cheng Guo. (2010). Alleviation of the acute doxorubicin-induced cardiotoxicity by Lycium barbarum polysaccharides through the suppression of oxidative stress. Food and Chemical Toxicology. 49(1). 259–264. 92 indexed citations
15.
Xin, Yanfei, Xin Li, Bin Hao, et al.. (2010). Indispensable but Insufficient Role of RenalD‐Amino Acid Oxidase in Chiral Inversion ofNG‐Nitro‐D‐arginine. Chemistry & Biodiversity. 7(6). 1413–1423. 3 indexed citations
16.
Xin, Yanfei, Liqiang Gu, Sheng Zhang, et al.. (2010). Stereospecific pharmacodynamics and chiral inversion of NG‐nitro‐arginine in the beagle dogs. Chirality. 22(10). 896–900. 1 indexed citations
17.
Xin, Yanfei, Guoliang Zhou, Yunxiang Chen, et al.. (2007). Angelica sinensis: A Novel Adjunct to Prevent Doxorubicin‐Induced Chronic Cardiotoxicity. Basic & Clinical Pharmacology & Toxicology. 101(6). 421–426. 28 indexed citations
18.
Xin, Yanfei. (2006). Effects of D-Amino Acid Oxidase on Chiral Inversion of N~G-nitro-D-arginine. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 2 indexed citations
19.
Xin, Yanfei, Xiangjun Zhou, Jie Lu, & Yong‐Xiang Wang. (2006). Inhibitory Effects of Benzoate on Chiral Inversion and Clearance of NG-Nitro-Arginine in Conscious Rats. Drug Metabolism and Disposition. 35(3). 331–334. 6 indexed citations
20.
Xin, Yanfei, Xiangjun Zhou, Xi Cheng, & Yong‐Xiang Wang. (2005). Renal d-Amino Acid Oxidase Mediates Chiral Inversion of NG-Nitro-d-arginine. Journal of Pharmacology and Experimental Therapeutics. 312(3). 1090–1096. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026